Showing results (2121-2130 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|August 15, 2009
Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cellsBo Li, Zhang Lei, Brain D Lichty, et al.
Cancer Immunology, Immunotherapy : CII|August 15, 2009
Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo)Cecilie Totland, Geir Bredholt, Mette Haugen, et al.
Cancer Immunology, Immunotherapy : CII|August 18, 2009
Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infectionI-Hsuan Chen, Yuen-Liang Lai, Chien-Liang Wu, et al.
Cancer Immunology, Immunotherapy : CII|August 20, 2009
A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivoJianxin Dai, Bohua Li, Jinping Shi, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2009
An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 contextYann Godet, Agnès Moreau-Aubry, Dimitri Mompelat, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2009
Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomasHelen P Cathro, Mark E Smolkin, Dan Theodorescu, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacityD M Finkelstein, R G Miller
Cancer Immunology, Immunotherapy : CII|April 8, 2009
Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequenceGuanglin Cui, Aping Yuan, Rasmus Goll, et al.
Cancer Immunology, Immunotherapy : CII|April 3, 2009
Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killingTimothy E Kute, Lori Savage, John R Stehle, et al.
Cancer Immunology, Immunotherapy : CII|March 31, 2009
An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 allelesYasunobu Terasaki, Shigeki Shichijo, Yamei Niu, et al.
Pageof 652